| Ashley Mcclary, MD, MPH | |
|
3828 S 1st St, Austin, TX 78704-7048 | |
| (512) 443-1311 | |
| Not Available |
| Full Name | Ashley Mcclary |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 3828 S 1st St, Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093158594 | NPI | - | NPPES |
| 1093158594 | Medicaid | NC |
| Entity Name | The Mcdowell Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699772657 PECOS PAC ID: 2264343979 Enrollment ID: O20031107000487 |
News Archive
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
A clue to the causes of autism and mental retardation lies in the synapse, the tiny intercellular junction that rapidly transfers information from one neuron to the next. According to neuroscientists at Tufts University School of Medicine, with students from the Sackler School of Graduate Biomedical Sciences at Tufts, a protein called APC plays a key role in synapse maturation, and APC dysfunction prevents the synapse function required for typical learning and memory.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced the initiation of a Phase 1 clinical study of ACE-041, a novel angiogenesis inhibitor that binds to and prevents members of the TGF-β superfamily from signaling through the activin receptor-like kinase 1 (ALK1) receptor.
As the Dearborn Community prepared for the impact of a project planned by Florida-based pastor Terry Jones, the Oakwood Healthcare System took another step toward celebrating the diversity of its patients, staff and community members.
The economic cost of methamphetamine use in the United States reached $23.4 billion in 2005, including the burden of addiction, premature death, drug treatment and many other aspects of the drug, according to a new RAND Corporation study.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Mcclary, MD, MPH 6210 E Hwy 290, Austin, TX 78723-1142 Ph: (512) 483-9596 | Ashley Mcclary, MD, MPH 3828 S 1st St, Austin, TX 78704-7048 Ph: (512) 443-1311 |
News Archive
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
A clue to the causes of autism and mental retardation lies in the synapse, the tiny intercellular junction that rapidly transfers information from one neuron to the next. According to neuroscientists at Tufts University School of Medicine, with students from the Sackler School of Graduate Biomedical Sciences at Tufts, a protein called APC plays a key role in synapse maturation, and APC dysfunction prevents the synapse function required for typical learning and memory.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced the initiation of a Phase 1 clinical study of ACE-041, a novel angiogenesis inhibitor that binds to and prevents members of the TGF-β superfamily from signaling through the activin receptor-like kinase 1 (ALK1) receptor.
As the Dearborn Community prepared for the impact of a project planned by Florida-based pastor Terry Jones, the Oakwood Healthcare System took another step toward celebrating the diversity of its patients, staff and community members.
The economic cost of methamphetamine use in the United States reached $23.4 billion in 2005, including the burden of addiction, premature death, drug treatment and many other aspects of the drug, according to a new RAND Corporation study.
› Verified 8 days ago
Dr. Carla Jeanne Thompson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12600 Hill Country Blvd, Suite R-103, Austin, TX 78738 Phone: 713-392-3055 | |
Dr. Lorraine E. Powell, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1912 W 35th St, Austin, TX 78703 Phone: 512-451-5161 Fax: 512-451-1258 | |
Alyssa Walden, Pediatrics Medicare: Medicare Enrolled Practice Location: 3000 N. I-35, Suite 770, Austin, TX 78705 Phone: 478-301-2600 | |
Dr. Anusha Chinthaparthi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9835 N Lake Creek Pkwy, Austin, TX 78717 Phone: 832-826-1380 Fax: 832-825-2799 | |
Elizabeth C. Knapp, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6835 Austin Center Blvd, Austin, TX 78731 Phone: 512-346-6611 Fax: 512-231-5204 | |
Scott A Broberg, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3816 S.1st St., Austin, TX 78704 Phone: 512-443-1311 Fax: 512-406-6266 | |
Roozbeh Taeed, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4900 Mueller Blvd # 2h.012c, Austin, TX 78723 Phone: 512-324-3360 Fax: 512-380-7532 |